We are live on ! Find out more
MOS

MGO One Seven Portfolio holdings

AUM $4.98B
1-Year Est. Return 22.72%
This Fund
S&P 500
This Quarter Est. Return
+7.8%
1 Year Est. Return
+22.72%
3 Year Est. Return
+73.8%
5 Year Est. Return
+90.34%
10 Year Est. Return
AUM
$716M
AUM Growth
+$133M
Cap. Flow
+$90M
Cap. Flow %
12.58%
Top 10 Hldgs %
18.21%
Holding
621
New
71
Increased
306
Reduced
191
Closed
31

Top Buys

Rank Stock Value
1
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$3.49M
2
AAPL icon
Apple
AAPL
+$3.33M
3
PODD icon
Insulet
PODD
+$3.24M
4
VTV icon
Vanguard Value ETF
VTV
+$3.12M
5
MSFT icon
Microsoft
MSFT
+$2.96M

Sector Composition

Rank Sector Weight
1 Technology 15.79%
2 Healthcare 9.33%
3 Financials 8.96%
4 Consumer Discretionary 7.63%
5 Industrials 6.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHK
576
PIMCO High Income Fund
PHK
$861M
$95K 0.01%
13,850
BGY icon
577
BlackRock Enhanced International Dividend Trust
BGY
$512M
$93K 0.01%
14,158
-2,025
-13% -$12.9K
EVGN icon
578
Evogene
EVGN
$6.57M
$92K 0.01%
2,688
-572
-18% -$22.4K
BBVA icon
579
Banco Bilbao Vizcaya Argentaria
BBVA
$144B
$90K 0.01%
14,533
-210
-1% -$1.24K
EAD
580
Allspring Income Opportunities Fund
EAD
$372M
$89K 0.01%
10,166
-12
-0.1% -$104
TCON
581
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$76K 0.01%
589
JQC icon
582
Nuveen Credit Strategies Income Fund
JQC
$702M
$70K 0.01%
+10,409
New +$68.9K
IGD
583
Voya Global Equity Dividend and Premium Opportunity Fund
IGD
$503M
$66K 0.01%
11,144
-1,235
-10% -$7.3K
AVEO
584
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$66K 0.01%
10,000
MIE
585
DELISTED
COHEN & STEERS MLP INCOME AND ENERGY OPPORTUNITY FUND, INC.
MIE
$57K 0.01%
14,075
+12
+0.1% +$44
TCRT icon
586
Alaunos Therapeutics
TCRT
$4.74M
$37K 0.01%
95
-20
-17% -$9.34K
TOON icon
587
Kartoon Studios
TOON
$34.3M
$27K ﹤0.01%
+1,471
New +$25.7K
GERN icon
588
Geron
GERN
$911M
$14K ﹤0.01%
10,000
DMK
589
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$12K ﹤0.01%
152
AMLP icon
590
Alerian MLP ETF
AMLP
$12.9B
-7,994
Closed -$243K
AZN icon
591
AstraZeneca
AZN
$263B
-4,846
Closed -$481K
BLOK icon
592
Amplify Blockchain Technology ETF
BLOK
$1.1B
-11,416
Closed -$637K
CVNA icon
593
Carvana
CVNA
$43.3B
-4,185
Closed -$219K
DEM icon
594
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.88B
-7,418
Closed -$329K
FLDR icon
595
Fidelity Low Duration Bond Factor ETF
FLDR
$1.95B
-4,280
Closed -$217K
FTSM icon
596
First Trust Enhanced Short Maturity ETF
FTSM
$6.51B
-3,636
Closed -$218K
GLW icon
597
Corning
GLW
$126B
-7,476
Closed -$325K
IDV icon
598
iShares International Select Dividend ETF
IDV
$8.25B
-9,830
Closed -$309K
IRBT
599
DELISTED
iRobot
IRBT
-2,024
Closed -$247K
LH icon
600
Labcorp
LH
$24.3B
-1,883
Closed -$412K

Similar funds

MGO One Seven's Q2 2021 Portfolio in Review

As of Q2 2021, MGO One Seven held 621 positions worth $716M, up 23% from $582M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

MGO One Seven deployed $90M of net new capital in Q2 2021, opening 71 new positions and adding to 306 existing holdings. Its largest new stake was Insulet: 11,922 shares worth $3.27M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $1.91M trimmed.

  • MGO One Seven's largest Q2 2021 buy was Insulet: 11,922 shares worth $3.27M.
  • MGO One Seven added most to JPMorgan Ultra-Short Income ETF in Q2 2021, an estimated $3.49M increase.
  • MGO One Seven's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $1.91M.
  • MGO One Seven fully exited iShares 1-3 Year Treasury Bond ETF in Q2 2021, selling an estimated $2.01M.
  • MGO One Seven's ten largest holdings make up 18% of its $716M portfolio in Q2 2021.
  • MGO One Seven opened 71 new positions and closed 31 in Q2 2021.
  • MGO One Seven's portfolio value rose 23% quarter-over-quarter to $716M.

Based on MGO One Seven's 13F filing for Q2 2021, filed 29 Jul 2021.